Resolvin E1 is a lipid modulator with potential therapeutic applications for asthma, rheumatoid arthritis, inflammatory bowel disease, and cardiovascular disorders. It promotes tear production, maintains corneal epithelial integrity, and reduces inflammatory COX-2 expression. In the stroma, it inhibits keratocyte transformation to myofibroblasts and decreases monocyte/macrophage presence. Reagent grade, for research purpose.
Usually ships within 24 hours.